PD-L1 upregulation by lytic induction of Epstein-Barr Virus - ScienceDirect
Por um escritor misterioso
Descrição
Cancers, Free Full-Text
Long-term antiretroviral therapy initiated in acute HIV infection prevents residual dysfunction of HIV-specific CD8+ T cells - eBioMedicine
Epstein–Barr Virus-Related Post-Transplant Lymphoproliferative Disorders: Pathogenetic Insights for Targeted Therapy - American Journal of Transplantation
RSV Downregulates IL-21/IL-21R On TFH Cells VIA PD-L1 Induction in APCS Impairing Protective Humoral Responses
Epstein‒Barr virus–associated cellular immunotherapy - Cytotherapy
Latency and lytic replication in Epstein–Barr virus-associated oncogenesis
PDF) Novel IRF8 and PD-L1 molecular aberrations in systemic EBV-positive T-cell lymphoma of childhood
Expression of PD-L1 in EBV-associated malignancies - ScienceDirect
PD-L1 upregulation by lytic induction of Epstein-Barr Virus - ScienceDirect
Rapid single-cell identification of Epstein–Barr virus-specific T-cell receptors for cellular therapy - Cytotherapy
Epstein–Barr virus latent genes Experimental & Molecular Medicine
The Enemy of My Enemy: New Insights Regarding Bacteriophage–Mammalian Cell Interactions: Trends in Microbiology
Epstein-Barr virus—recent advances - The Lancet Infectious Diseases
Role of the Epstein–Barr virus-encoded latent membrane protein-1, LMP1, in the pathogenesis of nasopharyngeal carcinoma
de
por adulto (o preço varia de acordo com o tamanho do grupo)
